- Have any questions?
- +91 90737 61769
- contact@cluegenix.net
Frederick Sanger (1977) developed a method for DNA sequencing based on the chain termination, now known as the Sanger sequencing. Recently, massive parallel sequencing, better known as next-generation sequencing (NGS), is replacing the Sanger sequencing for detecting mutations in many diseases. But till date, Sanger sequencing is still considered as the gold standard and also the first-line approach for the molecular diagnosis of many diseases.
Cluegenix is a San Francisco based company focused on making translational genomics technologies accessible globally to enable quick detection of diseases at scale.
Get The Latest Updates via email. Any time you may unsubscribe